Sierra Maria A, Wheeler Jack C W, Devereux Lisa, Trainer Alison H, Keogh Louise
Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
Centre for Health Equity, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC 3000, Australia.
J Pers Med. 2021 Sep 30;11(10):992. doi: 10.3390/jpm11100992.
Personal Breast Cancer (BC) Risk Assessments (PBCRA) have potential to stratify women into clinically-actionable BC risk categories. As this could involve population-wide genomic testing, women's attitudes to PBCRA and views on acceptable implementation platforms must be considered to ensure optimal population participation. We explored these issues with 31 women with different BC risk profiles through semi-structured focus group discussions or interviews. Inductive thematic coding of transcripts was performed. Subsequently, women listed factors that would impact on their decision to participate. Participants' attitudes to PBCRA were positive. Identified themes included that PBCRA acceptance hinges on result actionability. Women value the ability to inform decision-making. Participants reported anxiety, stress, and genetic discrimination as potential barriers. The age at which PBCRA was offered, ease of access, and how results are returned held importance. Most women value the opportunity for PBCRA to inform increased surveillance, while highlighting hesitance to accept reduced surveillance as they find reassurance in regular screening. Women with pathogenic variants value the potential for PBCRA to identify a lower cancer risk and potentially inform delayed prophylactic surgery. This study highlights complexities in adopting advances in BC early detection, especially for current users who value existing processes as a social good.
个人乳腺癌(BC)风险评估(PBCRA)有潜力将女性分层到临床可采取行动的BC风险类别中。由于这可能涉及全人群的基因检测,必须考虑女性对PBCRA的态度以及对可接受实施平台的看法,以确保最佳的人群参与度。我们通过半结构化焦点小组讨论或访谈,与31名具有不同BC风险特征的女性探讨了这些问题。对访谈记录进行了归纳主题编码。随后,女性列出了会影响她们参与决策的因素。参与者对PBCRA的态度是积极的。确定的主题包括,PBCRA的接受取决于结果的可采取行动性。女性重视为决策提供信息的能力。参与者报告焦虑、压力和基因歧视是潜在障碍。提供PBCRA的年龄、获取的便利性以及结果的反馈方式很重要。大多数女性重视PBCRA为加强监测提供信息的机会,同时强调在接受减少监测方面的犹豫,因为她们在定期筛查中能找到安心感。携带致病变体的女性重视PBCRA识别较低癌症风险并可能为延迟预防性手术提供信息的潜力。这项研究凸显了在采用BC早期检测进展方面的复杂性,特别是对于那些将现有流程视为社会公益的当前使用者而言。